Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Verastem Reports on Ongoing Trials at Cancer Advance at Harvard Medical School
Yahoo
Friday, September 20, 2013 - 10:18am
tags:
clinical trials, Harvard, Verastem, Defactinib, mesothelioma
There's still support for repealing the medtech tax, AdvaMed says
Mass Device
Friday, September 20, 2013 - 10:03am
tags:
AdvaMed, devices, medical device tax
Merck R&D Head Bets Slashing Bureaucracy Will Unlock Innovation
Forbes
Friday, September 20, 2013 - 10:02am
tags:
Merck, Roger Perlmutter, R&D, innovation
The Strategy Behind Encouraging Pharma R&D Managers To Bet Their Jobs On Projects
Forbes
Friday, September 20, 2013 - 10:01am
tags:
R&D
Novo Nordisk Hemophilia-A Treatment Wins EU Panel Backing
Bloomberg
Friday, September 20, 2013 - 9:54am
tags:
Novo Nordisk, Europe, hemophilia A, NovoEight
Roche CEO Says Drugmaker Isn’t Seeking Financing for Deal
Bloomberg
Friday, September 20, 2013 - 9:53am
tags:
Roche, Pharma CEOs, Severin Schwan, M&A, Biomarin
Isis reaches a new high on tests for treatment of muscular disorder
Marketwatch
Friday, September 20, 2013 - 9:50am
tags:
Isis Pharmaceuticals, spinal muscular atrophy, ISIS-SMNRx
Can Sanofi Get Back On Track?
Seeking Alpha
Friday, September 20, 2013 - 9:45am
tags:
Sanofi
Lundbeck, Otsuka get positive opinion for schizophrenia drug
Reuters
Friday, September 20, 2013 - 9:42am
tags:
Otsuka, Lundbeck, Europe, schizophrenia, Abilify Maintena
GSK, Prosensa muscular dystrophy drug misses study goal
Reuters
Friday, September 20, 2013 - 9:36am
tags:
GSK, Prosensa, drisapersen, Duchenne Muscular Dystrophy
Sanofi settles suit over obesity drug, Bloomberg says
Bloomberg
Friday, September 20, 2013 - 9:29am
tags:
Sanofi, obesity, Zimulti
IPO Preview: BIND Therapeutics
Seeking Alpha
Friday, September 20, 2013 - 9:27am
tags:
Bind Therapeutics, IPOs, cancer, nanomedicine
Sanofi CEO: Thanks to Genzyme, investors take us seriously
Fierce Pharma
Thursday, September 19, 2013 - 2:11pm
tags:
Sanofi, Genzyme, M&A, Pharma CEOs, Chris Viehbacher
Theravance, GSK get positive opinion from EMA for Relvar Ellipta
The Fly on the Wall
Thursday, September 19, 2013 - 1:48pm
tags:
GSK, Theravance, Relvar Ellipta, COPD, Europe
Layoffs ahead for Covidien
Mass Device
Thursday, September 19, 2013 - 11:17am
tags:
devices, layoffs, Covidien
With new tools, Novartis targets brain disease
Boston Globe, MA
Thursday, September 19, 2013 - 11:14am
tags:
Novartis, Cambridge, Neurosciences
[video]Do Fish Oil Drugmakers Need to Worry About Generics?
Motley Fool
Thursday, September 19, 2013 - 11:11am
tags:
generics, Amarin, Vascepa, Lovaza, GSK
Asia: Healthcare's Biggest M&A Opportunity And Challenge
Forbes
Thursday, September 19, 2013 - 11:05am
tags:
M&A, Asia
Aerie Pharma jumps into IPO game with $58M pitch to investors
Fierce Biotech
Thursday, September 19, 2013 - 8:21am
tags:
Aerie Pharma, IPOs
Google's biotech plan: Partner with legendary CEO, tackle aging, think outside the cancer box
Fierce Biotech
Thursday, September 19, 2013 - 8:19am
tags:
Google, biotech, aging, Larry Page, Art Levinson, Calico

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.